{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T02:10:07Z","timestamp":1744164607494,"version":"3.40.3"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2008,11,13]],"date-time":"2008-11-13T00:00:00Z","timestamp":1226534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2008,11,13]],"date-time":"2008-11-13T00:00:00Z","timestamp":1226534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Glycoconj J"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1007\/s10719-008-9212-y","type":"journal-article","created":{"date-parts":[[2008,11,12]],"date-time":"2008-11-12T09:59:50Z","timestamp":1226483990000},"page":"663-673","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["UDP-Gal: N-acetylglucosamine \u03b2 1\u20134 galactosyltransferase expressing live attenuated parasites as vaccine for visceral leishmaniasis"],"prefix":"10.1007","volume":"26","author":[{"given":"Siddhartha Kumar","family":"Bhaumik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manoj Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subir","family":"Karmakar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tripti","family":"De","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,11,13]]},"reference":[{"key":"9212_CR1","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.cimid.2004.03.004","volume":"27","author":"P. Desjeux","year":"2004","unstructured":"Desjeux, P.: Leishmaniasis: current situation and new perspectives. Comp. Immunol. Microbiol. Infect. Dis. 27, 305\u2013318 (2004)","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"9212_CR2","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1128\/AAC.45.8.2185-2197.2001","volume":"45","author":"H.W. Murray","year":"2001","unstructured":"Murray, H.W.: Clinical and experimental advances in treatment of visceral leishmaniasis. Antimicrob. Agents Chemother. 45, 2185\u20132197 (2001)","journal-title":"Antimicrob. Agents Chemother."},{"key":"9212_CR3","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/0165-6147(88)90258-1","volume":"9","author":"S.L. Croft","year":"1988","unstructured":"Croft, S.L.: Recent development in the chemotherapy of leishmaniasis. Trends Pharmacol. Sci. 9, 376\u2013381 (1988)","journal-title":"Trends Pharmacol. Sci."},{"key":"9212_CR4","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/infdis\/157.5.973","volume":"157","author":"H.W. Murray","year":"1988","unstructured":"Murray, H.W., Berman, J.D., Wright, S.D.: Immunochemotherapy for intracellular Leishmania donovani infection: \u03b3-interferon plus pentavalent antimony. J. Infect. Dis. 157, 973\u2013978 (1988)","journal-title":"J. Infect. Dis."},{"key":"9212_CR5","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1128\/AAC.47.8.2397-2403.2003","volume":"47","author":"F.J. Perez-Victoria","year":"2003","unstructured":"Perez-Victoria, F.J., Castanys, S., Gamarro, F.: Leishmania donovani resistance to miltefosine involves a defective inward translocation of the drug. Antimicrob. Agents Chemother. 47, 2397\u20132403 (2003)","journal-title":"Antimicrob. Agents Chemother."},{"key":"9212_CR6","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/S1473-3099(02)00372-9","volume":"2","author":"P.J. Guerin","year":"2002","unstructured":"Guerin, P.J., Olliaro, P., Nosten, F., Druilhe, P., Laxminarayan, R., Binka, F., Kilama, W.L., Ford, N., White, N.J.: Malaria: current status of control, diagnosis, treatment, and a proposed agenda for research and development. Lancet Infect. Dis. 2, 564\u2013573 (2002)","journal-title":"Lancet Infect. Dis."},{"key":"9212_CR7","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1086\/318121","volume":"31","author":"S. Sundar","year":"2000","unstructured":"Sundar, S., More, D.K., Singh, M.K., Singh, V.P., Sharma, S., Makharia, A., Kumar, P.C., Murray, H.W.: Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic. Clin. Infect. Dis. 31, 1104\u20131107 (2000)","journal-title":"Clin. Infect. Dis."},{"key":"9212_CR8","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4269\/ajtmh.1992.47.117","volume":"47","author":"M. Grogl","year":"1992","unstructured":"Grogl, M., Thomason, T.N., Franke, E.D.: Drug resistance in leishmaniasis: its implication in systemic chemotherapy of cutaneous and mucocutaneous disease. Am. J. Trop. Med. Hyg. 47, 117\u2013126 (1992)","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"9212_CR9","doi-asserted-by":"crossref","first-page":"464","DOI":"10.4269\/ajtmh.1990.43.464","volume":"43","author":"J.E. Jackson","year":"1990","unstructured":"Jackson, J.E., Tally, J.D., Ellis, W.Y., Mebrahtu, Y.B., Lawyer, P.G., Were, J.B., Reed, S.G., Panisko, D.M., Limmer, B.L.: Quantitative in vitro drug potency and drug susceptibility evaluation of Leishmania spp. from patients unresponsive to pentavalent antimony. Am. J. Trop. Med. Hyg. 43, 464\u2013480 (1990)","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"9212_CR10","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/S0140-6736(05)67629-5","volume":"366","author":"H.W. Murray","year":"2005","unstructured":"Murray, H.W., Berman, J.D., Davies, C.R., Saravia, N.G.: Advances in leishmaniasis. Lancet. 366, 1561\u20131577 (2005)","journal-title":"Lancet."},{"key":"9212_CR11","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.pt.2005.03.006","volume":"21","author":"R.N. Coler","year":"2005","unstructured":"Coler, R.N., Reed, S.G.: Second-generation vaccines against leishmaniasis. Trends Parasitol. 21, 44\u201349 (2005)","journal-title":"Trends Parasitol."},{"key":"9212_CR12","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1111\/j.1365-2249.1991.tb05663.x","volume":"83","author":"S.C. Mendonca","year":"1991","unstructured":"Mendonca, S.C., Russell, D.G., Coutinho, S.G.: Analysis of the human T cell responsiveness to purified antigens of Leishmania: lipophosphoglycan (LPG) and glycoprotein 63 (gp 63). Clin. Exp. Immunol. 83, 472\u2013478 (1991)","journal-title":"Clin. Exp. Immunol."},{"key":"9212_CR13","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/S0140-6736(00)03128-7","volume":"356","author":"E.A. Khalil","year":"2000","unstructured":"Khalil, E.A., El Hassan, A.M., Zijlstra, E.E., Mukhtar, M.M., Ghalib, H.W., Musa, B., Ibrahim, M.E., Kamil, A.A., Elsheikh, M., Babiker, A., Modabber, F.: Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomized, double-blind, BCG-controlled trial in Sudan. Lancet. 356, 1565\u20131569 (2000)","journal-title":"Lancet."},{"key":"9212_CR14","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1016\/S0140-6736(98)09552-X","volume":"351","author":"I. Sharifi","year":"1998","unstructured":"Sharifi, I., FeKri, A.R., Aflatonian, M.R., Khamesipour, A., Nadim, A., Mousavi, M.R., Momeni, A.Z., Dowlati, Y., Godal, T., Zicker, F., Smith, P.G., Modabber, F.: Randomized vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, Iran. Lancet. 351, 1540\u20131543 (1998)","journal-title":"Lancet."},{"key":"9212_CR15","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S1471-4922(01)02163-8","volume":"17","author":"E. Handman","year":"2001","unstructured":"Handman, E.: Protective saliva: a novel approach to a Leishmania vaccine. Trends Parasitol. 17, 513\u2013514 (2001)","journal-title":"Trends Parasitol."},{"key":"9212_CR16","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s10719-007-9098-0","volume":"25","author":"S.K. Bhaumik","year":"2008","unstructured":"Bhaumik, S.K., Singh, M., Basu, R., Bhaumik, S., Roychoudhury, K., Naskar, K., Roy, S., De, T.: Virulence attenuation of a UDP-galactose\/N-acetylglucosamine beta1,4 galactosyltransferase expressing Leishmania donovani promastigote. Glycoconj J. 25, 459\u2013472 (2008)","journal-title":"Glycoconj J."},{"key":"9212_CR17","first-page":"80","volume":"45","author":"L.A. Stauber","year":"1958","unstructured":"Stauber, L.A.: Host resistance to Khartoum strain of Leishmania donovani. Rice Inst. Pam. 45, 80\u201383 (1958)","journal-title":"Rice Inst. Pam."},{"key":"9212_CR18","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.4049\/jimmunol.166.3.1912","volume":"166","author":"P.C. Melby","year":"2001","unstructured":"Melby, P.C., Chandrasekar, B., Zhao, W., Coe, J.E.: The hamster as a model of human visceral leishmaniasis: progressive disease and impaired generation of nitric oxide in the face of a prominent Th1-like cytokine response. J. Immunol. 166, 1912\u20131920 (2001)","journal-title":"J. Immunol."},{"key":"9212_CR19","doi-asserted-by":"publisher","first-page":"54","DOI":"10.2307\/3285699","volume":"85","author":"T. De","year":"1999","unstructured":"De, T., Roy, S.: Infectivity and attenuation of Leishmania donovani promastigotes: association of galactosyl transferase with loss of parasite virulence. J. Parasitol. 85, 54\u201359 (1999)","journal-title":"J. Parasitol."},{"key":"9212_CR20","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1042\/bj1860827","volume":"186","author":"J. Schlepper-Sch\u00e4fer","year":"1980","unstructured":"Schlepper-Sch\u00e4fer, J., Kolb-Bachofen, V., Kolb, H.: Analysis of lectin-dependent recognition of desialylated erythrocytes by Kupffer cells. Biochem. J. 186, 827\u2013831 (1980)","journal-title":"Biochem. J."},{"key":"9212_CR21","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1128\/CDLI.7.2.233-240.2000","volume":"7","author":"S. Mukhopadhyay","year":"2000","unstructured":"Mukhopadhyay, S., Bhattacharyya, S., Majhi, R., De, T., Naskar, K., Majumdar, S., Roy, S.: Use of an attenuated leishmanial parasite as an immunoprophylactic and immunotherapeutic agent against murine visceral leishmaniasis. Clin. Diagn. Lab. Immunol. 7, 233\u2013240 (2000)","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"9212_CR22","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1126\/science.2470147","volume":"244","author":"S. Roy","year":"1989","unstructured":"Roy, S., Scherer, M.T., Briner, T.J., Smith, J.A., Gefter, M.L.: Murine MHC polymorphism and T cell specificities. Science. 244, 572\u2013575 (1989)","journal-title":"Science."},{"key":"9212_CR23","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S0065-2776(08)60536-2","volume":"54","author":"R.L. Coffman","year":"1993","unstructured":"Coffman, R.L., Lehman, D.A., Rothman, P.: Mechanism and regulation of immunoglobulin isotype switching. Adv. Immunol. 54, 229\u2013270 (1993)","journal-title":"Adv. Immunol."},{"key":"9212_CR24","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1128\/CMR.14.2.229-243.2001","volume":"14","author":"E. Handman","year":"2001","unstructured":"Handman, E.: Leishmaniasis: current status of vaccine development. Clin. Microbiol. Rev. 14, 229\u2013243 (2001)","journal-title":"Clin. Microbiol. Rev."},{"key":"9212_CR25","first-page":"423","volume":"123","author":"A. Khamesipour","year":"2006","unstructured":"Khamesipour, A., Rafati, S., Davoudi, N., Maboudi, F., Modabber, F.: Leishmaniasis vaccine candidates for development: a global overview Ind. J. Med. Res. 123, 423\u2013438 (2006)","journal-title":"J. Med. Res."},{"key":"9212_CR26","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1086\/374783","volume":"87","author":"H. Daneshvar","year":"2003","unstructured":"Daneshvar, H., Coombs, G.H., Hagan, P., Phillips, R.S.: Leishmania mexicana and Leishmania major: attenuation of wild-type parasites and vaccination with the attenuated lines. J. Infect. Dis. 87, 1662\u20131668 (2003)","journal-title":"J. Infect. Dis."},{"key":"9212_CR27","doi-asserted-by":"publisher","first-page":"10267","DOI":"10.1073\/pnas.92.22.10267","volume":"92","author":"R.G. Titus","year":"1995","unstructured":"Titus, R.G., Gueiros-Filho, F.J., de Freitas, L.A., Beverley, S.M.: Development of a safe live Leishmania vaccine line by gene replacement. Proc. Natl. Acad. Sci. U. S. A. 92, 10267\u201310271 (1995)","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"9212_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0008-8749(85)90080-2","volume":"94","author":"R.M. Gorczynski","year":"1985","unstructured":"Gorczynski, R.M.: Immunization of susceptible BALB\/c mice against Leishmania braziliensis. I. Resistance induced using as immunogen adherent or nonadherent cells from infected mice. Cell. Immunol. 94, 1\u201310 (1985)","journal-title":"Cell. Immunol."},{"key":"9212_CR29","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1128\/IAI.70.1.62-68.2002","volume":"70","author":"B. Papadopoulou","year":"2002","unstructured":"Papadopoulou, B., Roy, G., Breton, M., Kundig, C., Dumas, C., Fillion, I., Singh, A.K., Olivier, M., Ouellette, M.: Reduced infectivity of a Leishmania donovani biopterin transporter genetic mutant and its use as an attenuated strain for vaccination. Infect. Immun. 70, 62\u201368 (2002)","journal-title":"Infect. Immun."},{"key":"9212_CR30","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1111\/j.0141-9838.2004.00671.x","volume":"25","author":"H. Daneshyar","year":"2003","unstructured":"Daneshyar, H., Hagan, P., Phillips, R.S.: Leishmania mexicana H-line attenuated under pressure of gentamicin, potentiates a Th1 response and control of cutaneous leishmaniasis in BALB\/c mice. Parasite Immunol. 25, 589\u2013596 (2003)","journal-title":"Parasite Immunol."},{"key":"9212_CR31","doi-asserted-by":"publisher","first-page":"5645","DOI":"10.1016\/j.vaccine.2006.03.023","volume":"24","author":"M. Calvopina","year":"2006","unstructured":"Calvopina, M., Barroso, P.A., Marco, J.D., Korenaga, M., Cooper, P.J., Nonaka, S., Hashiguchi, Y.: Efficacy of vaccination with a combination of Leishmania amastigote antigens and the lipid A-analogue ONO-4007 for immunoprophylaxis and immunotherapy against Leishmania amazonensis infection in a murine model of New World cutaneous leishmaniasis. Vaccine. 24, 5645\u20135652 (2006)","journal-title":"Vaccine."},{"key":"9212_CR32","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S0264-410X(98)90017-2","volume":"17","author":"S. Mukhopadhyay","year":"1999","unstructured":"Mukhopadhyay, S., Sen, P., Bhattacharyya, S., Majumdar, S., Roy, S.: Immunoprophylaxis and immunotherapy against experimental visceral leishmaniasis. Vaccine. 17, 291\u2013300 (1999)","journal-title":"Vaccine."},{"key":"9212_CR33","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0065-308X(08)60208-0","volume":"32","author":"F.Y. Liew","year":"1993","unstructured":"Liew, F.Y., O\u2019Donnell, C.A.: Immunology of leishmaniasis. Adv. Parasitol. 32, 161\u2013169 (1993)","journal-title":"Adv. Parasitol."},{"key":"9212_CR34","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.4049\/jimmunol.154.9.4623","volume":"154","author":"H.W. Galib","year":"1995","unstructured":"Galib, H.W., Whittle, J.A., Kubin, M., Hashim, F.A., el-Hassan, A.M., Grabstein, K.H., Trinchieri, G., Reed, S.S.: IL-12 enhances Th1-type responses in human Leishmania donovani infections. J. Immunol. 154, 4623\u20134629 (1995)","journal-title":"J. Immunol."},{"key":"9212_CR35","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1084\/jem.185.7.1231","volume":"185","author":"A. Taylor","year":"1997","unstructured":"Taylor, A., Mur, , ray, H.W.: Intracellular antimicrobial activity in the absence of interferon-\u03b3: effect of interleukin 12 in experimental visceral leishmaniasis in interferon-\u03b3 gene-disrupted mice. J. Exp. Med. 185, 1231\u20131239 (1997)","journal-title":"J. Exp. Med."},{"key":"9212_CR36","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1126\/science.7904381","volume":"263","author":"L.C. Afonso","year":"1994","unstructured":"Afonso, L.C., Scharton, T.M., Vieira, L.Q., Wysocka, M., Trinchieri, G., Scott, P.: The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science. 263, 235\u20137 (1994)","journal-title":"Science."},{"key":"9212_CR37","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/ni0901-816","volume":"2","author":"K.J. Maloy","year":"2001","unstructured":"Maloy, K.J., Powrie, F.: Regulatory T cells in the control of immune pathology. Nat. Immunol. 2, 816\u2013822 (2001)","journal-title":"Nat. Immunol."},{"key":"9212_CR38","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1084\/jem.20021345","volume":"197","author":"K.J. Maloy","year":"2003","unstructured":"Maloy, K.J., Salaun, L., Cahill, R., Dougan, G., Saunders, N.J., Powrie, F.: CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J. Exp. Med. 197, 111\u2013119 (2003)","journal-title":"J. Exp. Med."},{"key":"9212_CR39","doi-asserted-by":"crossref","first-page":"4819","DOI":"10.4049\/jimmunol.164.9.4819","volume":"164","author":"H. Himmelrich","year":"2000","unstructured":"Himmelrich, H., Maillard, I., Biedermann, T., Tacchini-Cottier, F., Locksley, R.M., Rocken, M., Louis, J.A.: In BALB\/c mice, IL-4 production during the initial phase of infection with Leishmania major is necessary and sufficient to instruct Th2 cell development resulting in progressive disease. J. Immunol. 164, 4819\u20134825 (2000)","journal-title":"J. Immunol."},{"key":"9212_CR40","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S1286-4579(99)80015-X","volume":"1","author":"P. Launois","year":"1999","unstructured":"Launois, P., Himmelrich, H., Tacchini-Cottier, F., Milon, G., Louis, J.A.: New insight into the mechanisms underlying Th2 cell development and susceptibility to Leishmania major in BALB\/c mice. Microbes Infect. 1, 59\u201364 (1999)","journal-title":"Microbes Infect."},{"key":"9212_CR41","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/sj.gene.6363977","volume":"4","author":"J.M. Blackweell","year":"2003","unstructured":"Blackweell, J.M., Ibrahim, M.E., Miller, E.N., Peacock, C.S., Khalil, E.A., Cordell, H.J., Howson, J.M., El Hassan, A.M., Bereir, R.E., Blackwell, J.M.: Genes Immun. 4, 351\u2013355 (2003)","journal-title":"Genes Immun."},{"key":"9212_CR42","doi-asserted-by":"publisher","first-page":"3621","DOI":"10.1002\/(SICI)1521-4141(199911)29:11<3621::AID-IMMU3621>3.0.CO;2-Z","volume":"29","author":"P. Kropf","year":"1999","unstructured":"Kropf, P., Schopf, L.R., Chung, C.L., Xu, D., Liew, F.Y., Sypek, J.P., Muller, J.P.: Expression of Th2 cytokines and the stable Th2 marker ST2L in the absence of IL-4 during Leishmania major infection. Eur. J. Immunol. 29, 3621\u20133628 (1999)","journal-title":"Eur. J. Immunol."},{"key":"9212_CR43","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/j.0105-2896.2004.00190.x","volume":"201","author":"D. McMahon-Pratt","year":"2004","unstructured":"McMahon-Pratt, D., Alexander, J.: Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease. Immunol. Rev. 201, 206\u2013224 (2004)","journal-title":"Immunol. Rev."},{"key":"9212_CR44","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1006\/expr.2001.4640","volume":"99","author":"P.C. Melby","year":"2001","unstructured":"Melby, P.C., Tabares, A., Restrepo, B.I., Cardona, A.E., McGruff, H.S., Teale, J.M.: Leishmania donovani: evolution and architecture of the splenic cellular immune response related to control of infection. Exp. Parasitol. 99, 17\u201325 (2001)","journal-title":"Exp. Parasitol."},{"key":"9212_CR45","doi-asserted-by":"publisher","first-page":"3903","DOI":"10.1128\/IAI.73.7.3903-3911.2005","volume":"73","author":"H.W. Murray","year":"2005","unstructured":"Murray, H.W., Flanders, K.C., Donaldson, D.D., Sypek, J.P., Gotwals, P.J., Liu, J., Ma, X, , .: Antagonizing deactivating cytokines to enhance host defense andchemotherapy in experimental visceral leishmaniasis. Infect. Immun. 73, 3903\u20133911 (2005)","journal-title":"Infect. Immun."},{"key":"9212_CR46","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1111\/j.1462-5822.2008.01146.x","volume":"10","author":"C. Bogdan","year":"2008","unstructured":"Bogdan, C.: Mechanisms and consequences of persistence of intracellular pathogens: leishmaniasis as an example. Cell. Microbiol. 10, 1221\u20131234 (2008)","journal-title":"Cell. Microbiol."},{"key":"9212_CR47","doi-asserted-by":"crossref","first-page":"908","DOI":"10.4049\/jimmunol.138.3.908","volume":"138","author":"D. Sacks","year":"1987","unstructured":"Sacks, D., Lal, S.L., Shrivastava, S.N., Blackwell, J., Neva, F.A.: An analysis of T cell responsiveness in Indian kala-azar. J. Immunol. 138, 908\u2013913 (1987)","journal-title":"J. Immunol."},{"key":"9212_CR48","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1128\/iai.62.1.229-235.1994","volume":"62","author":"E. Pinelli","year":"1994","unstructured":"Pinelli, E., Killick-Kendrick, R., Wagenaar, J., Bernadina, W., del Real, G., Ruitenberg, J.: Cellular and humoral immune responses in dogs experimentally and naturally infected with Leishmania infantum. Infect. Immun. 62, 229\u2013235 (1994)","journal-title":"Infect. Immun."},{"key":"9212_CR49","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1590\/S0100-879X1998000100012","volume":"31","author":"R.T. Gazzinelli","year":"1998","unstructured":"Gazzinelli, R.T., Talvani, A., Camargo, M.M., Santiago, H.C., Oliveira, M.A., Vieira, L.Q., Martins, G.A., Aliberti, J.C., Silva, J.S.: Induction of cell-mediated immunity during early stages of infection with intracellular protozoa. Braz. J. Med. Biol. Res. 31, 89\u2013104 (1998)","journal-title":"Braz. J. Med. Biol. Res."},{"key":"9212_CR50","first-page":"951","volume":"9","author":"S. Sundar","year":"2002","unstructured":"Sundar, S., Rai, M.: Laboratory diagnosis of visceral leishmaniasis. Clin. Diag. Lab. Immunol. 9, 951\u2013958 (2002)","journal-title":"Clin. Diag. Lab. Immunol."},{"key":"9212_CR51","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/S0169-4758(97)01060-0","volume":"13","author":"E. Hamndman","year":"1997","unstructured":"Hamndman, E.: Leishmania vaccine: old and new. Parasitol. Today. 13, 236\u2013238 (1997)","journal-title":"Parasitol. Today."},{"key":"9212_CR52","doi-asserted-by":"crossref","first-page":"762","DOI":"10.4269\/ajtmh.1981.30.762","volume":"30","author":"T.W. Holbrook","year":"1981","unstructured":"Holbrook, T.W., Cook, J.A., Parker, E.W.: Immunization against Leishmania donovani: glucan as an adjuvant with killed promastigotes. Am. J. Trop. Med. Hyg. 30, 762\u2013768 (1981)","journal-title":"Am. J. Trop. Med. Hyg."}],"container-title":["Glycoconjugate Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10719-008-9212-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10719-008-9212-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10719-008-9212-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10719-008-9212-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T01:36:40Z","timestamp":1744162600000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10719-008-9212-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,13]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["9212"],"URL":"https:\/\/doi.org\/10.1007\/s10719-008-9212-y","relation":{},"ISSN":["0282-0080","1573-4986"],"issn-type":[{"type":"print","value":"0282-0080"},{"type":"electronic","value":"1573-4986"}],"subject":[],"published":{"date-parts":[[2008,11,13]]},"assertion":[{"value":"26 April 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2008","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2008","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2008","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}